<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Procept Biorobotics Corp — News on 6ix</title>
<link>https://6ix.com/company/procept-biorobotics-corp</link>
<description>Latest news and press releases for Procept Biorobotics Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 09 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/procept-biorobotics-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b02278dffbe2df10f8af.webp</url>
<title>Procept Biorobotics Corp</title>
<link>https://6ix.com/company/procept-biorobotics-corp</link>
</image>
<item>
<title>PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-to-report-first-quarter-2026-financial-results-on-april-29-2026</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-to-report-first-quarter-2026-financial-results-on-april-29-2026</guid>
<pubDate>Thu, 09 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2026 after market close on Wednesday, April 29, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to</description>
</item>
<item>
<title>Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/sonder-capital-closes-its-second-fund-and-announces-participation-from-major-healthcare-systems-1</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/sonder-capital-closes-its-second-fund-and-announces-participation-from-major-healthcare-systems-1</guid>
<pubDate>Tue, 24 Mar 2026 15:03:00 GMT</pubDate>
<description>Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II.</description>
</item>
<item>
<title>EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/eau-guidelines-upgrade-aquablationr-therapy-to-strong-surgical-recommendation-for-bph</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/eau-guidelines-upgrade-aquablationr-therapy-to-strong-surgical-recommendation-for-bph</guid>
<pubDate>Mon, 23 Mar 2026 04:00:00 GMT</pubDate>
<description>Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign</description>
</item>
<item>
<title>PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-announces-international-launch-of-the-hydrosr-robotic-system-expanding-global-access-to-ai-enabled-aquablationr-therapy-29</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-announces-international-launch-of-the-hydrosr-robotic-system-expanding-global-access-to-ai-enabled-aquablationr-therapy-29</guid>
<pubDate>Thu, 12 Mar 2026 04:00:00 GMT</pubDate>
<description>UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March 12, 2026</description>
</item>
<item>
<title>PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-hosts-2026-investor-day-to-detail-multi-year-financial-outlook-and-strategic-plan-for-long-term-growth</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-hosts-2026-investor-day-to-detail-multi-year-financial-outlook-and-strategic-plan-for-long-term-growth</guid>
<pubDate>Thu, 26 Feb 2026 12:55:00 GMT</pubDate>
<description>Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational disciplineStrong revenue outlook, procedure growth, expanding margins, and path to profitabilityLonger-term growth drivers include market expansion and expanded application into prostate cancer NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advanc</description>
</item>
<item>
<title>PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-fourth-quarter-2025-financial-results-and-updates-2026-revenue-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-fourth-quarter-2025-financial-results-and-updates-2026-revenue-guidance</guid>
<pubDate>Wed, 25 Feb 2026 21:02:00 GMT</pubDate>
<description>SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended December 31, 2025. “In the fourth quarter, we delivered our highest procedure volume to date—approximately 12,200—and sold 65 new systems, marking our strongest capital quarter,” said Larry Wood, Chief Exe</description>
</item>
<item>
<title>PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-announces-updated-dates-for-4q25-earnings-conference-call-and-investor-day</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-announces-updated-dates-for-4q25-earnings-conference-call-and-investor-day</guid>
<pubDate>Mon, 23 Feb 2026 21:03:00 GMT</pubDate>
<description>SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that it has updated the timing of its previously announced fourth quarter 2025 earnings conference call and Investor Day due to significant travel disruptions caused by inclement weather. The Company will report financial results for the fourth quarter of</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-attend-td-cowen-210300704</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-attend-td-cowen-210300704</guid>
<pubDate>Wed, 04 Feb 2026 21:03:00 GMT</pubDate>
<description>SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March. TD Cowen 46th Annual Health Care Conference Location – Boston, MAFireside Chat – Monday, March 2nd at 11:40am ET 2026 Leerink Global Health Care Conference Location – Miami, FLFire</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-host-4q25-earnings-210300664</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-host-4q25-earnings-210300664</guid>
<pubDate>Mon, 26 Jan 2026 21:03:00 GMT</pubDate>
<description>SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, February 24, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. The Company also announced it will ho</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-present-upcoming-37th-annual-piper-sandler-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-present-upcoming-37th-annual-piper-sandler-healthcare-conference</guid>
<pubDate>Thu, 20 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing</description>
</item>
<item>
<title>PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-third-quarter-2025-financial-results-and-issues-2026</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-third-quarter-2025-financial-results-and-issues-2026</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-report-third-quarter-2025-financial-results-november-4-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-report-third-quarter-2025-financial-results-november-4-2025-2025</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on</description>
</item>
<item>
<title>PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-second-quarter-2025-financial-results-and-increases-2025</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-second-quarter-2025-financial-results-and-increases-2025</guid>
<pubDate>Wed, 06 Aug 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on</description>
</item>
<item>
<title>PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-president-and-ceo-dr-reza-zadno-retire-company-appoints-larry-l</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-president-and-ceo-dr-reza-zadno-retire-company-appoints-larry-l</guid>
<pubDate>Thu, 24 Jul 2025 04:00:00 GMT</pubDate>
<description>Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of</description>
</item>
<item>
<title>Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/ambulatory-surgery-center-completes-water-120000114</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/ambulatory-surgery-center-completes-water-120000114</guid>
<pubDate>Wed, 23 Jul 2025 12:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three prostate cancer procedures in the WATER IV Prostate Cancer (PCa) Trial were successfully completed in an Ambulatory Surgery Center (ASC) using Aquablation® therapy by Dr. Rahul Mehan of East Valley Urology in Scottsdale, Arizona. WATER IV PCa is a U.</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-report-second-quarter-2025-financial-results-august-6-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-report-second-quarter-2025-financial-results-august-6-2025-2025</guid>
<pubDate>Mon, 21 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on</description>
</item>
<item>
<title>Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/aquablationr-therapys-assigned-category-i-code-2026-medicare-proposed-physician-fee</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/aquablationr-therapys-assigned-category-i-code-2026-medicare-proposed-physician-fee</guid>
<pubDate>Mon, 14 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to</description>
</item>
<item>
<title>PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-attend-four-upcoming-investor-conferences-may-june-2025-04-29</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-bioroboticsr-attend-four-upcoming-investor-conferences-may-june-2025-04-29</guid>
<pubDate>Tue, 29 Apr 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing</description>
</item>
<item>
<title>PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-aquablation-therapy-spotlighted-2025-aua-annual-meeting-along</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-aquablation-therapy-spotlighted-2025-aua-annual-meeting-along</guid>
<pubDate>Thu, 24 Apr 2025 04:00:00 GMT</pubDate>
<description>Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System</description>
</item>
<item>
<title>PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance</title>
<link>https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-first-quarter-2025-financial-results-and-increases-2025</link>
<guid isPermaLink="true">https://6ix.com/company/procept-biorobotics-corp/news/procept-biorobotics-reports-first-quarter-2025-financial-results-and-increases-2025</guid>
<pubDate>Thu, 24 Apr 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on</description>
</item>
</channel>
</rss>